Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 2 1Phase 1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 230NETWORK 138NIH 106INDUSTRY 24OTHER_GOV 10UNKNOWN 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Thoracic 1

Conditions

Breast Neoplasms 2Thymoma 1

Interventions

Paclitaxel 6Radiotherapy 3Epirubicin 3Radiation Dose Hypofractionation 2Radiation 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Capecitabine 2pegylated granulocyte colony-stimulating factor 1nabiximols 1aumolertinib 1Zoledronic Acid 1Vinorelbine 1Temozolomide 1TP protocol 1Standard of Care 1S 1 (combination) 1Radiotherapy, Intensity-Modulated 1Platinum 1Pemetrexed 1Neoadjuvant Therapy 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Decitabine 1Chemotherapy, Adjuvant 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Radiotherapy × Clear all
NCT04646564 2022-01-11

Radiotherapy for Extracranial Oligometastatic Breast Cancer

ChineseAMS

Phase 3 Unknown
170 enrolled
Breast

Breast Neoplasms

NCT02014805 2020-07-16

Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma

ChineseAMS

Phase 3 Unknown
210 enrolled
Thoracic

Thymoma

NCT00793962 2018-10-11

A Phase â…¢ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

ChineseAMS

Phase 3 Completed
810 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡